Literature DB >> 7795602

A gene responsible for cavernous malformations of the brain maps to chromosome 7q.

J Dubovsky1, J M Zabramski, J Kurth, R F Spetzler, S S Rich, H T Orr, J L Weber.   

Abstract

Cavernous malformations of the brain are vascular lesions which are present in up to 0.4% of all individuals and which are often accompanied by seizures, migraine, hemorrhage and other neurologic problems. Using linkage analysis and a set of short tandem repeat polymorphisms, a gene responsible for cavernous malformations in a large Hispanic kindred was mapped to the q11-q22 region of chromosome 7. A maximum pairwise lod score of 4.2 was obtained at zero recombination with marker PY5-18 at locus D7S804. Lod scores in excess of 3.0 were obtained with four additional markers closely linked to PY5-18. A broad chromosome 7q haplotype of 33 cM length on the sex average map was shared by all affected individuals indicating that the gene lies between loci D7S502 and D7S479.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7795602     DOI: 10.1093/hmg/4.3.453

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  49 in total

1.  Krit1 missense mutations lead to splicing errors in cerebral cavernous malformation.

Authors:  Dominique J Verlaan; Adrian M Siegel; Guy A Rouleau
Journal:  Am J Hum Genet       Date:  2002-04-08       Impact factor: 11.025

2.  Familial cavernous malformations in a large French kindred: mapping of the gene to the CCM1 locus on chromosome 7q.

Authors:  L Notelet; F Chapon; S Khoury; K Vahedi; J P Chodkiewicz; P Courtheoux; M T Iba-Zizen; E A Cabanis; B Lechevalier; E Tournier-Lasserve; J P Houtteville
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

3.  Systems biology and proteomic analysis of cerebral cavernous malformation.

Authors:  Alexander R Edelmann; Sarah Schwartz-Baxter; Christopher F Dibble; Warren C Byrd; Jim Carlson; Ivandario Saldarriaga; Sompop Bencharit
Journal:  Expert Rev Proteomics       Date:  2014-03-31       Impact factor: 3.940

4.  Different spectra of genomic deletions within the CCM genes between Italian and American CCM patient cohorts.

Authors:  Christina L Liquori; Silvana Penco; Judith Gault; Tracey P Leedom; Laura Tassi; Teresa Esposito; Issam A Awad; Luigi Frati; Eric W Johnson; Ferdinando Squitieri; Douglas A Marchuk; Fernando Gianfrancesco
Journal:  Neurogenetics       Date:  2007-12-01       Impact factor: 2.660

5.  Case report: glioblastoma multiforme complicating familial cavernous malformations.

Authors:  D M Wilson; B Cohen; K Keshari; H Vogel; G Steinberg; W Dillon
Journal:  Clin Neuroradiol       Date:  2013-08-14       Impact factor: 3.649

Review 6.  Genetics of cerebral cavernous malformations: current status and future prospects.

Authors:  H Choquet; L Pawlikowska; M T Lawton; H Kim
Journal:  J Neurosurg Sci       Date:  2015-04-22       Impact factor: 2.279

Review 7.  Signaling pathways and the cerebral cavernous malformations proteins: lessons from structural biology.

Authors:  Oriana S Fisher; Titus J Boggon
Journal:  Cell Mol Life Sci       Date:  2013-11-29       Impact factor: 9.261

8.  Genetic Screening of Pediatric Cavernous Malformations.

Authors:  Elisa Merello; Marco Pavanello; Alessandro Consales; Samantha Mascelli; Alessandro Raso; Andrea Accogli; Armando Cama; Capra Valeria; Patrizia De Marco
Journal:  J Mol Neurosci       Date:  2016-08-25       Impact factor: 3.444

9.  Defining the functional domain of programmed cell death 10 through its interactions with phosphatidylinositol-3,4,5-trisphosphate.

Authors:  Christopher F Dibble; Jeremy A Horst; Michael H Malone; Kun Park; Brenda Temple; Holly Cheeseman; Justin R Barbaro; Gary L Johnson; Sompop Bencharit
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

10.  Intramedullary cavernoma presenting with hematomyelia: report of two girls.

Authors:  Erwin M J Cornips; Pauline A C P Vinken; Mariel Ter Laak-Poort; Emile A M Beuls; Jacobine Weber; Johannes S H Vles
Journal:  Childs Nerv Syst       Date:  2009-10-29       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.